Stocks Overview

LAST PRICE
42.3500
TODAY'S CHANGE (%)
Trending Up0.0400 (0.0945%)

Bid / Lots
42.3500/ 1
Ask / Lots
42.6900/ 10
Open / Previous Close
42.2200 / 42.3100
Day Range
Low 42.1900
High 42.4400
52 Week Range
Low 19.5900
High 43.5898
Volume
1,083,367
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 42.31
Time	Volume	CERE
09:32 ET	1963	42.3
09:34 ET	100	42.3
09:36 ET	4112	42.35
09:38 ET	31209	42.365
09:39 ET	16248	42.35
09:41 ET	5068	42.25
09:43 ET	14939	42.25
09:45 ET	5553	42.26
09:48 ET	15443	42.25
09:50 ET	300	42.25
09:52 ET	943	42.27
09:54 ET	18143	42.26
09:56 ET	1200	42.255
09:57 ET	200	42.255
09:59 ET	436	42.26
10:01 ET	300	42.275
10:03 ET	400	42.28
10:06 ET	700	42.26
10:08 ET	1800	42.25
10:10 ET	8250	42.29
10:12 ET	815	42.28
10:14 ET	200	42.28
10:15 ET	245	42.275
10:17 ET	100	42.27
10:19 ET	500	42.265
10:21 ET	100	42.26
10:24 ET	400	42.28
10:26 ET	17531	42.26
10:28 ET	1300	42.25
10:30 ET	1548	42.255
10:32 ET	800	42.25
10:33 ET	1441	42.26
10:35 ET	400	42.255
10:37 ET	422	42.25
10:39 ET	12128	42.27
10:42 ET	3404	42.24
10:44 ET	5257	42.24
10:46 ET	100	42.235
10:48 ET	700	42.24
10:50 ET	300	42.235
10:51 ET	2251	42.27
10:53 ET	2300	42.33
10:55 ET	1168	42.32
10:57 ET	414	42.3
11:00 ET	400	42.31
11:02 ET	3261	42.28
11:04 ET	775	42.27
11:08 ET	1039	42.3
11:09 ET	300	42.31
11:11 ET	300	42.31
11:13 ET	100	42.305
11:15 ET	15007	42.26
11:18 ET	1980	42.24
11:22 ET	100	42.235
11:24 ET	14509	42.28
11:26 ET	1291	42.28
11:27 ET	800	42.275
11:29 ET	4900	42.29
11:31 ET	1046	42.29
11:33 ET	200	42.28
11:36 ET	1016	42.31
11:38 ET	300	42.32
11:40 ET	100	42.325
11:42 ET	409	42.325
11:44 ET	2100	42.31
11:45 ET	200	42.31
11:47 ET	700	42.3
11:49 ET	1233	42.3
11:51 ET	1027	42.29
11:54 ET	301	42.295
11:56 ET	100	42.29
11:58 ET	100	42.29
12:00 ET	201	42.295
12:02 ET	8473	42.285
12:03 ET	478	42.28
12:05 ET	2202	42.28
12:07 ET	9857	42.27
12:09 ET	6000	42.26
12:12 ET	600	42.26
12:14 ET	356	42.26
12:18 ET	891	42.25
12:20 ET	1800	42.24
12:21 ET	500	42.24
12:23 ET	200	42.245
12:25 ET	500	42.245
12:30 ET	200	42.245
12:32 ET	2705	42.245
12:34 ET	1229	42.245
12:36 ET	5300	42.25
12:38 ET	1000	42.255
12:39 ET	1400	42.26
12:41 ET	3493	42.245
12:43 ET	568	42.24
12:45 ET	300	42.25
12:50 ET	2505	42.255
12:52 ET	700	42.26
12:57 ET	200	42.255
12:59 ET	100	42.255
01:01 ET	500	42.255
01:06 ET	400	42.255
01:10 ET	100	42.255
01:12 ET	597	42.255
01:14 ET	1864	42.285
01:15 ET	400	42.3
01:24 ET	1515	42.29
01:26 ET	100	42.27
01:28 ET	300	42.28
01:33 ET	580	42.265
01:35 ET	300	42.26
01:37 ET	200	42.26
01:42 ET	200	42.265
01:44 ET	100	42.26
01:46 ET	6474	42.245
01:48 ET	1400	42.245
01:50 ET	2300	42.25
01:51 ET	1900	42.25
01:53 ET	56899	42.25
01:55 ET	908	42.2375
01:57 ET	3400	42.24
02:00 ET	200	42.24
02:02 ET	26407	42.25
02:04 ET	100	42.24
02:06 ET	1204	42.25
02:08 ET	800	42.245
02:09 ET	2300	42.245
02:11 ET	3807	42.26
02:13 ET	1587	42.26
02:15 ET	26360	42.255
02:18 ET	25307	42.27
02:20 ET	5193	42.255
02:22 ET	4912	42.25
02:24 ET	5678	42.29
02:26 ET	24533	42.25
02:27 ET	3475	42.25
02:29 ET	5364	42.25
02:31 ET	6048	42.26
02:33 ET	1500	42.2799
02:36 ET	700	42.255
02:38 ET	600	42.25
02:40 ET	3183	42.25
02:42 ET	1500	42.245
02:44 ET	2722	42.255
02:45 ET	600	42.255
02:47 ET	9594	42.285
02:49 ET	2200	42.295
02:51 ET	300	42.3
02:54 ET	203	42.305
02:56 ET	1200	42.32
02:58 ET	300	42.32
03:00 ET	406	42.315
03:02 ET	9008	42.295
03:03 ET	12963	42.285
03:05 ET	6910	42.265
03:07 ET	41441	42.25
03:09 ET	900	42.25
03:12 ET	1236	42.235
03:14 ET	1000	42.24
03:16 ET	824	42.235
03:18 ET	1000	42.235
03:20 ET	1062	42.245
03:21 ET	2500	42.24
03:23 ET	1726	42.245
03:25 ET	1229	42.25
03:27 ET	12157	42.285
03:30 ET	3728	42.28
03:32 ET	16643	42.265
03:34 ET	5228	42.32
03:36 ET	1900	42.325
03:38 ET	1600	42.35
03:39 ET	1764	42.34
03:41 ET	3008	42.36
03:43 ET	2172	42.35
03:45 ET	8944	42.34
03:48 ET	1341	42.315
03:50 ET	7756	42.295
03:52 ET	9570	42.295
03:54 ET	7631	42.295
03:56 ET	9359	42.31
03:57 ET	13581	42.305
03:59 ET	31620	42.35

Data delayed at least 15 minutes.

Yesterday
- ACQUISITION ALERT BFA LLP Notifies Cerevel Therapeutics Shareholders of an Investigation into the Merger with AbbVie, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
- BFA LLP Reminds Cerevel Therapeutics Shareholders of the Investigation into Merger with AbbVie and Encourages Investors to Contact the Firm, from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
May 15, 2024
- MERGER NEWS NASDAQ CERE BFA Law Investigates Cerevel Therapeutics Merger with AbbVie Encourages Shareholders to Contact the Firm, from 4:09PM ET on Wednesday May 15, 2024 by Dow Jones
  4:09PM ET on Wednesday May 15, 2024 by Dow Jones
- MERGER ALERT CERE Is $45 per CERE Share Fair? Top Law Firm BFA LLP Investigating Cerevel Therapeutics Merger with AbbVie, from 8:33AM ET on Wednesday May 15, 2024 by Dow Jones
  8:33AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
- NASDAQ CERE INVESTIGATION ALERT Leading Law Firm BFA LLP Notifies CERE Shareholders of Investigation into the Cerevel Therapeutics Merger with AbbVie Contact Firm for More Information, from 4:04PM ET on Tuesday May 14, 2024 by Dow Jones
  4:04PM ET on Tuesday May 14, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCERE Cerevel Therapeutics Holdings Inc	7.7B	-15.6x	---
United StatesPCVX Vaxcyte Inc	7.8B	-17.9x	---
United StatesVKTX Viking Therapeutics Inc	8.6B	-74.2x	---
United StatesRVMD Revolution Medicines Inc	6.5B	-10.4x	---
United StatesCYTK Cytokinetics Inc	6.3B	-11.1x	---
United StatesASND Ascendis Pharma A/S	7.2B	-12.7x	---
As of 2024-05-17

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4). Darigabat is a PAM that selectively targets the alpha 2/3/5 subunits of the GABAA receptor. Tavapadon is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of Parkinson’s disease.

Contact Information

Headquarters: 222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
Phone: 212-284-2300
Fax: 302-636-5454

Executives

Chairperson of the Board of Directors: N. Coles
President, Chief Executive Officer, Member of the Board: Ronald Renaud
Chief Financial Officer: Susan Altschuller
Chief Human Resources Officer: Kenneth Dipietro
Senior Vice President - Finance, Chief Accounting Officer: Mark Bodenrader

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$7.7B
Revenue (TTM)	$0.00
Shares Outstanding	181.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.44
EPS	$-2.72
Book Value	$3.71
P/E Ratio	-15.6x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Cerevel Therapeutics Holdings Inc
NASDAQ:CEREUnited States

Search Criteria

Charts

Recent News

Yesterday

ACQUISITION ALERT BFA LLP Notifies Cerevel Therapeutics Shareholders of an Investigation into the Merger with AbbVie, from 8 hours ago by Dow Jones

BFA LLP Reminds Cerevel Therapeutics Shareholders of the Investigation into Merger with AbbVie and Encourages Investors to Contact the Firm, from 15 hours ago by Dow Jones

May 15, 2024

MERGER NEWS NASDAQ CERE BFA Law Investigates Cerevel Therapeutics Merger with AbbVie Encourages Shareholders to Contact the Firm, from 4:09PM ET on Wednesday May 15, 2024 by Dow Jones

MERGER ALERT CERE Is $45 per CERE Share Fair? Top Law Firm BFA LLP Investigating Cerevel Therapeutics Merger with AbbVie, from 8:33AM ET on Wednesday May 15, 2024 by Dow Jones

May 14, 2024

NASDAQ CERE INVESTIGATION ALERT Leading Law Firm BFA LLP Notifies CERE Shareholders of Investigation into the Cerevel Therapeutics Merger with AbbVie Contact Firm for More Information, from 4:04PM ET on Tuesday May 14, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar